CORC

浏览/检索结果: 共5条,第1-5条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Discovery of JND3229 as a New EGFR(C797S) Mutant Inhibitor with In Vivo Monodrug Efficacy 期刊论文
ACS MEDICINAL CHEMISTRY LETTERS, 2018, 卷号: 9, 期号: 11, 页码: 1123-1127
作者:  Lu, Xiaoyun;  Zhang, Tao;  Zhu, Su-Jie;  Xun, Qiuju;  Tong, Lingjiang
收藏  |  浏览/下载:108/0  |  提交时间:2019/01/08
Discovery of 2,4,6-trisubstitued pyrido[3,4-d]pyrimidine derivatives as new EGFR-TKIs 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 148, 页码: 221-237
作者:  Zhang, Hao;  Wang, Jin;  Shen, Ying;  Wang, Hui-Yan;  Duan, Wei-Ming
收藏  |  浏览/下载:8/0  |  提交时间:2019/11/26
Structural insights into drug development strategy targeting EGFR T790M/C797S 期刊论文
Oncotarget, 2018, 卷号: Vol.9 No.17, 页码: 13652-13665
作者:  Zhu, S.-J.;  Zhao, P.;  Yang, J.;  Ma, R.;  Yan, X.-E.
收藏  |  浏览/下载:12/0  |  提交时间:2019/02/25
Discovery of JND3229 as a New EGFR(C797S) Mutant Inhibitor with In Vivo Monodrug Efficacy 期刊论文
2018, 卷号: 9, 期号: 11, 页码: 1123
作者:  Lu, Xiaoyun[1];  Zhang, Tao[2,6,7];  Zhu, Su-Jie[3,4];  Xun, Qiuju[5];  Tong, Lingjiang[2]
收藏  |  浏览/下载:24/0  |  提交时间:2019/12/23
Targeting EGFR(L858R/T790M) and EGFR(L858R/T790M/C797S) resistance mutations in NSCLC: Current developments in medicinal chemistry 期刊论文
2018, 卷号: 38, 期号: 5, 页码: 1550
作者:  Lu, Xiaoyun[1];  Yu, Lei[2];  Zhang, Zhang[1];  Ren, Xiaomei[1];  Smaill, Jeff B.[3,4]
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/06


©版权所有 ©2017 CSpace - Powered by CSpace